BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26359566)

  • 1. FDG PET brain scan demonstrated glucose hypometabolism of bilateral caudate nuclei and putamina in a patient with chorea-acanthocytosis.
    Cui R; You H; Niu N; Li F
    Clin Nucl Med; 2015 Dec; 40(12):979-80. PubMed ID: 26359566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of
    López-Mora DA; Camacho V; Fernandez A; Fuentes F; Pérez-Pérez J; Carrio I
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(5):328-329. PubMed ID: 29208484
    [No Abstract]   [Full Text] [Related]  

  • 3. A Case of Chorea-Acanthocytosis with FDG PET/CT Imaging.
    Uslu H; Orhan Varoğlu A; Tatoglu MT; Kılıçaslan E
    Nuklearmedizin; 2022 Aug; 61(4):347-348. PubMed ID: 35388440
    [No Abstract]   [Full Text] [Related]  

  • 4. Striking lack of visualization of striatum on
    López-Mora DA; Camacho V; Fernández A; Granell E; Carrió I
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):511-512. PubMed ID: 29242959
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study.
    Tanaka M; Hirai S; Kondo S; Sun X; Nakagawa T; Tanaka S; Hayashi K; Okamoto K
    Mov Disord; 1998 Jan; 13(1):100-7. PubMed ID: 9452334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain FDG-PET showing striatal hypometabolism in a case of chorea-acanthocytosis.
    Rubí S; Oporto M; García A; Legarda I; Picado MJ; Peña C
    Rev Esp Med Nucl Imagen Mol; 2016; 35(3):205-6. PubMed ID: 26522005
    [No Abstract]   [Full Text] [Related]  

  • 7. Putaminal Hypometabolism Exceeding Caudate Abnormalities on 18F-FDG PET in Huntington Disease.
    Singhal T; Kim CK
    Clin Nucl Med; 2017 Jul; 42(7):e343-e344. PubMed ID: 28418951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chorea-acanthocytosis without chorea: Expanding the clinical phenotype.
    Peluso S; Bilo L; Esposito M; Antenora A; De Rosa A; Pappatà S; De Michele G
    Parkinsonism Relat Disord; 2017 Aug; 41():124-126. PubMed ID: 28551324
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and brain 18fluoro-2-deoxyglucose positron emission tomographic findings in ethylmalonic aciduria, a progressive neurometabolic disease.
    al-Essa MA; al-Shamsan LA; Ozand PT
    Eur J Paediatr Neurol; 1999; 3(3):125-7. PubMed ID: 10461568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose Hypermetabolism in Contralateral Basal Ganglia Demonstrated by Serial FDG PET/CT Scans in a Patient With SLE Chorea.
    Niu N; Cui R
    Clin Nucl Med; 2017 Jan; 42(1):64-65. PubMed ID: 27819860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of glucose metabolism in basal ganglia diagnosed with FDG-PET scan: a neuroacanthocytosis case.
    Selcuk NA; Fenercioglu A
    Clin Nucl Med; 2010 Jul; 35(7):557-8. PubMed ID: 20548161
    [No Abstract]   [Full Text] [Related]  

  • 12. Automatic striatal volumetry allows for identification of patients with chorea-acanthocytosis at single subject level.
    Huppertz HJ; Kröll-Seger J; Danek A; Weber B; Dorn T; Kassubek J
    J Neural Transm (Vienna); 2008 Oct; 115(10):1393-400. PubMed ID: 18648728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 123I-ioflupane SPECT findings of pantothenate kinase-associated neurodegeneration.
    Kang A; Minoshima S
    Clin Nucl Med; 2014 Sep; 39(9):849-51. PubMed ID: 24999676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep brain stimulation of the globus pallidus internal improves symptoms of chorea-acanthocytosis.
    Li P; Huang R; Song W; Ji J; Burgunder JM; Wang X; Zhong Q; Kaelin-Lang A; Wang W; Shang HF
    Neurol Sci; 2012 Apr; 33(2):269-74. PubMed ID: 21863267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.
    Akman CI; Provenzano F; Wang D; Engelstad K; Hinton V; Yu J; Tikofsky R; Ichese M; De Vivo DC
    Epilepsy Res; 2015 Feb; 110():206-15. PubMed ID: 25616474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminating chorea-acanthocytosis from Huntington's disease with single-case voxel-based morphometry analysis.
    Suzuki F; Sato N; Ota M; Sugiyama A; Shigemoto Y; Morimoto E; Kimura Y; Wakasugi N; Takahashi Y; Futamura A; Kawamura M; Ono K; Nakamura M; Sano A; Watanabe M; Matsuda H; Abe O
    J Neurol Sci; 2020 Jan; 408():116545. PubMed ID: 31704285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroacanthocytosis and aprebetalipoproteinemia.
    Bohlega S; Riley W; Powe J; Baynton R; Roberts G
    Neurology; 1998 Jun; 50(6):1912-4. PubMed ID: 9633762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chorea and contraceptives: case report with pet study and review of the literature.
    Vela L; Sfakianakis GN; Heros D; Koller W; Singer C
    Mov Disord; 2004 Mar; 19(3):349-52. PubMed ID: 15022195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.